BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
Total Debt Over TimeCompressed
Percentile Rank14
3Y CAGR-16.2%
5Y CAGR-10.0%
Studio
Year-over-Year Change

Sum of short-term and long-term debt obligations

3Y CAGR
-16.2%/yr
vs +7.1%/yr prior
5Y CAGR
-10.0%/yr
Recent deceleration
Acceleration
-23.3pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineCompressed
PeriodValueYoY Change
2025$642.87M-1.0%
2024$649.47M-40.7%
2023$1.10B+0.2%
2022$1.09B+0.4%
2021$1.09B+0.2%
2020$1.09B+26.6%
2019$858.82M+3.4%
2018$830.42M-29.3%
2017$1.17B+71.9%
2016$683.24M-